Verified
Sarepta Therapeutics
Pharmaceuticals
Founded: 2002
Headquarters: 215 First Street, Cambridge, Massachusetts 02142, USA
Overview
Location
Massachusetts, United States
Headquarter
215 First Street, Cambridge, Massachusetts 02142, USA
Contact Number
6172744000
No of Employees
1700
Industry
Pharmaceuticals
Contact Email
Not Available
Company Type
Public Company
Website
Founded
2002
CEO
Douglas S. Ingram
Codes
SIC Code 28,283 | NAICS Code 32,325
Annual Revenue
1.25 Billion USD
Total Funding
$2.8B
Recent Funding Amount
$250M
No of Funding Rounds
17
Founders
Louis K. Chang
Company Overview
Established in 1980, Sarepta Therapeutics conducts research on and manufactures pharmaceuticals used to treat genetic diseases. This company is headquartered in Cambridge, Massachusetts.
Employees by Level
C-Level
6
VP-Level
57
Director
1
Manager
370
Non-Manager
504
Top Contacts
1308
Top C-suite Members of Company
Connect with key decision-makers at Sarepta Therapeutics. View contact details of C-suite executives and leadership team.
| Name | Title | Contact | |
|---|---|---|---|
| Douglas Ingram | Chief Executive Officer | d****m@sarepta.com | |
| Diane Berry | Global Health Policy Vice President | d****y@sarepta.com | |
| Ian Estepan | Executive VP | i****n@sarepta.com | |
| Nixon Luc | Sciences Director | n****c@sarepta.com | |
| Kirsten Meisterling | Senior Director | k****g@sarepta.com | |
| Cris Rothfuss | Executive VP | c****s@sarepta.com | |
| Alison Nasisi | Vice President | a****i@sarepta.com | |
| Django Andrews | Executive Director | d****s@sarepta.com | |
| Ryan Brown | General Counsel | r****n@sarepta.com | |
| Katrina Cahill | Head Vice President | k****l@sarepta.com | |
| Charles Gerrits | Global Senior VP | c****s@sarepta.com | |
| Peter O'Hanley | Senior VP | p****y@sarepta.com | |
| Ian Estepan | Executive VP | i****n@sarepta.com | |
| Cris Rothfuss | Executive VP | c****s@sarepta.com | |
| Cristin Rothfuss | Senior Vice President | c****s@sarepta.com | |
| Kirsten Meisterling | Senior Director | k****g@sarepta.com |
Employees Contact
Are you Seeking to connect with decision-makers? Acquire their contact info, including emails and phone numbers, from credible sources like LinkedIn or trusted websites.
| Name | Position | Phone | Profile | |
|---|---|---|---|---|
April Davis | Associate Director, Clinical Development Compliance | ******7714 | a.......s@biogen.com | |
Erron Deloney | Senior Manager | *******2137 | e.......y@charter.net | |
Justin Abrams | Senior Associate, Global Supply Chain And Logistics | ******4385 | j.......s@aubonpain.com | |
Michael Krutsinger | Facilities | ******3700 | b.......g@centurytel.net | |
Lisa Conti | Qa Engineer | ******4000 | l.......i@sarepta.com | |
Terry Ashe | Associate Director, East Account Team | ******3700 | t.......e@comcast.net | |
Christopher Verni | Vp, Chief Intellectual Property Counsel | ******3700 | c.......i@gmail.com | |
Joe Zenkus | Vice President, Business Development And Strategic Alliances | ******4951 | j.......7@london.edu | |
Johannes Dworzak | Duchenne Account Manager | ******3700 | j.......k@gmail.com | |
Jonathan Platt | Senior Manager, Gene Therapy Ms And T | ******5592 | m.......5@gmail.com | |
Stephen Dietrich | Senior Associate, Api Process Development And Characterization | ******3700 | f.......4@hotmail.com | |
Josh Haggerty | Talent Acquisition Commercial Hr Partner | ******4000 | j.......s@yahoo.com | |
Jill Murray | Hr Business Partner | ******2500 | j.......y@immunogen.com | |
Kathryn Giblin | Medical Director | ******0270 | k.......n@biogen.com | |
Marissa Steele | Senior Clinical Research Associate | *******0088 | m.......e@sarepta.com | |
Ken Hawkins | Senior Director, Network Strategy And Planning | ******3234 | k.......s@biogenidec.com | |
Valerie Shea | Senior Director, Us Marketing | ******8688 | v.......a@gmail.com | |
Xiao Ni | Senior Director, Biostatistics | ******4896 | m.......e@gmail.com | |
Richard Reynolds | Quality Assurance | ******6075 | r.......0@comcast.net | |
Benjamin Simeone | Director, Gene Therapy Drug Substance Operations | ******2480 | b.......e@gmail.com | |
Arun Rooj | Scientist Ii | ******0564 | a.......j@sarepta.com | |
Jennifer Cromwell | Senior Environmental, Health And Safety Manager | ******3568 | n.......8@yahoo.com | |
Kevin Kim | Director Of Lead Discovery | ******7027 | k.......m@csmc.edu | |
Anthony Scaccia | Senior Associate, Outsourced | ******0415 | a.......5@gmail.com | |
Mark Mcgill | Duchenne Account Manager | ******9540 | m.......l@interceptpharma.com | |
Cindy Gibson | Senior Associate | ******3700 | c.......n@sarepta.com | |
Ju Li | Principal Scientist | ******3700 | j.......i@gmail.com | |
Douglas Williams | Senior Manager, Compensation | ******1351 | w.......s@gmail.com | |
Cassie Gray | Rare Disease Nurse Educator -tardis | ******4835 | c.......y@quintilesims.com | |
Josanna Holzapfel | Manager Of Subunit Chemistry And Control Account Manager | ******6454 | j.......l@sarepta.com | |
Peter Burch | Associate Director | ******3115 | p.......h@pfizer.com | |
Ashish Dugar | Vice President, Global Medical Affairs | ******3115 | a.......r@sarepta.com | |
Heather Avakemian | Associate Director, Duchenne Account Manager West Team | ******3700 | h.......n@sarepta.com | |
Clarissa Diniz | Associate Director, Us Marketing | ******1661 | c.......z@ptcbio.com | |
Mary Smith | Duchenne Reimbursement Manager | ******3700 | m.......h@sarepta.com | |
Stephanie Miller | Duchenne Account Manager | *******2222 | s.......r@neurogesx.com | |
Sharon Crugnale | Executive Director, Head Of Clinical Operations | *******7570 | s.......e@genzyme.com | |
Mansi R.ph | Associate Director Pharmacovigilance Operations | ******3030 | m.......h@amgen.com | |
Ingrid Greene | Purchasing | ******3700 | i.......e@sarepta.com | |
Yifan Zhao | Senior Accountant | *******1117 | y.......n@eduboston.com | |
Liz Smyth | Senior Director Medical Affairs And Msl Team Leader | *******9038 | l.......h@sarepta.com | |
Robert Reddick | Senior Director, Qa Validation And Technical Transfer | ******7709 | r.......k@yahoo.com | |
Cheryl Donahue | Director, National Accounts | ******3700 | c.......e@sarepta.com | |
Julie Poore | Senior Manager, Alliance Operations | *******0000 | j.......e@quintiles.com | |
Jonathan Lu | Medical | ******4000 | j.......u@sarepta.com | |
Courtney Kincaid | Manager, Clinical Trials | ******3700 | c.......d@sarepta.com | |
Tara Clark | Senior Director | *******7041 | t.......c@broadinstitute.org | |
Derek Rau | Manager | ******3700 | d.......u@sarepta.com | |
Ryan Vogel | Duchenne Account Manager | ******3700 | r.......l@optonline.net | |
Sharad Wankhade | Associate Director | ******7677 | s.......w@hotmail.com | |
Robert Langevin | Senior Manager, Chief Marketing Officer Support And Technician Transfer | ******4900 | r.......n@msn.com | |
Tammy Burke | Senior Director, Global Study Feasibility And Patient Recruitment | ******0028 | t.......a@hotmail.com | |
Janet Howard | Entrepreneur, Mother, Student, Cook And Domestic Goddess | ******3700 | j.......d@sareptatherapeutics.com | |
Morgan Weeks | Senior Manager, Nucleoside Analytics | ******3700 | m.......s@siga.com | |
Emily Chong | Manager, Nucleoside Manufacturing And Proccess Engineering | ******3700 | e.......g@sarepta.com | |
Leanne Winters | Executive Assistant | ******5094 | w.......a@gmail.com | |
Brock Ueda | Environment, Health And Safety Manager | *******8063 | b.......a@yahoo.com | |
Amy Duncan | Commercial Training | ******3700 | a.......7@comcast.net | |
Fred D'amato | Director | *******7679 | f.......o@sarepta.com | |
Max Stewart | Translational Development | ******0529 | m.......w@gmail.com | |
Cindi Crawford | Duchenne Account Manager | ******4827 | c.......h@mac.com | |
Simon Zelazo | Associate Director | *******5931 | s.......o@gmail.com | |
Karen Bulaklak | Senior Scientist - Dmd Gene Editing | *******4601 | k.......k@unc.edu | |
Elke Blaetz | Director, Global Medical Information | ******8924 | e.......z@mac.com | |
Adi Osovsky | Director, Corporate Law | ******5576 | a.......y@gmail.com | |
Murat Karadeniz | Associate Director, Regulatory Affairs Cmc | *******7570 | m.......z@genzyme.com | |
Jon White | Senior Director, Head Of Underwriting Specialist Sales | ******3700 | j.......e@sarepta.com | |
Leeanna Hoskins | Senior Director - Payer Access | ******3700 | l.......s@sarepta.com | |
Will Tilton | Vice President Corporate Strategy And Program Management | ******8903 | w.......n@shire.com | |
Nelsa Estrella | Scientist | ******9403 | n.......r@gmail.com | |
Damon Asher | Director, Global Medical Affairs, Gene Therapy | ******8581 | d.......r@post.harvard.edu | |
Steven Lazar | Duchenne Account Manager - Southeast | ******3700 | s.......r@hyperiontx.com | |
Robin Hall | Associate Manager, Qa Operations | ******0003 | r.......0@yahoo.com | |
Kelly Bourdon | Clinical Trial Manager Ii | ******5533 | k.......3@hotmail.com | |
Dawna Kraft | Case Manager | *******9060 | d.......t@organo.com | |
Joe Acosta | Manager, It Systems Operations | ******3700 | j.......a@versalogic.com | |
Daniel Ferreira | Regulatory Cmc | ******6830 | d.......a@msn.com | |
Stephanie Stepanchick | Project Manager | ******3700 | s.......k@sarepta.com | |
Richard Azaroff | Senior Validation Engineer | ******3154 | r.......f@comcast.net | |
Daniela Kropf | Quality Control | ******3700 | d.......a@hotmail.com | |
Alex Park | Director, Regulatory Affairs Cmc | *******9325 | a.......k@gmail.com | |
Shawn Marlow | Senior Manager, Commercial Operations And Analytics | ******3568 | m.......5@rocketmail.com | |
Mary Smith | Duchenne Account Manager | ******3700 | m.......h@sarepta.com | |
Louis Fernandes | Clinical Trial Manager Ii | ******9868 | l.......3@gmail.com | |
Kaitlin Duffy | Associate Director, Human Resources Business Partner | ******9445 | k.......y@gmail.com | |
Gunnar Hanson | Research Chemistry | ******3700 | g.......1@aol.com | |
Rita Amirana | Senior Director, Global Development Strategy And Clinical Operations | ******7001 | r.......s@hotmail.com | |
Biswarup Dasgupta | Director, Quality Assurance, Gene Therapy | ******7817 | b.......a@genzyme.com | |
Bilal Arif | Vice President, Head Of Strategy And Operations | ******9700 | b.......f@momentapharma.com | |
Jill Sullivan | Associate Director, Alliance Management | ******9140 | m.......n@gmail.com | |
Robert Fay | Facilities | ******3700 | m.......m@verizon.net | |
Angela Delucco | Associate Director, Talent Acquisition | ******1895 | a.......o@yahoo.com | |
Adam Chevalier | Nucleoside Manufacturing Devolpment | ******3700 | a.......r@sarepta.com | |
David Cory | Director, Learning And Development And Talent | ******1574 | l.......y@gte.net | |
John Hohmann | Finance Consultant | *******3094 | j.......n@constantcontact.com | |
Alison Nasisi | Senior Director, Global Total Rewards | *******7000 | a.......i@forrester.com | |
Tammy Griffin | Associate Director, Global Quality Systems | ******6700 | t.......n@comcast.net | |
Rob Palermo | Market Access At Sarepta Therapeutics | ******3700 | r.......o@sarepta.com | |
Peter Burke | Associate Director, Manufacturing Sciences And Technologies | ******4500 | p.......e@hotmail.com | |
Emily Naughton | Associate Director, Medical Affairs Operations | ******3700 | e.......n@sarepta.com |
Email Formats
Discover the email patterns used at Sarepta Therapeutics to connect with the right people.
| Email Format | Example | Percentage |
|---|---|---|
| firstname.lastname@company.com | john.doe@company.com | 45% |
| firstname@company.com | john@company.com | 30% |
| firstinitial.lastname@company.com | j.doe@company.com | 15% |
| firstname_lastname@company.com | john_doe@company.com | 10% |
View Email formats of the company.
Email Verification Tool
Get verified email addresses of any IBM employee. Enjoy 100 free lookups every month.
Enter a person's name or an email address to verify
Technology Stack
Frequently Asked Questions
What is the address of Sarepta Therapeutics's headquarters?
Sarepta Therapeutics is headquartered at 215 First Street, Cambridge, Massachusetts 02142, USA.
How can I contact Sarepta Therapeutics by phone?
You can reach Sarepta Therapeutics by calling their customer support number at 6172744000.
Which stock symbol does Sarepta Therapeutics trade under?
The stock ticker for Sarepta Therapeutics is SRPT.
What is the official website for Sarepta Therapeutics?
You can visit Sarepta Therapeutics's official website at www.sarepta.com.
How much revenue does Sarepta Therapeutics generate?
Sarepta Therapeutics reports an annual revenue of approximately 1.25 Billion USD.
What is the SIC code for Sarepta Therapeutics?
The Standard Industrial Classification (SIC) code for Sarepta Therapeutics is 28,283.
What is the NAICS code for Sarepta Therapeutics?
Sarepta Therapeutics falls under the NAICS code 32,325.
How many people work at Sarepta Therapeutics?
Sarepta Therapeutics has a workforce of about 1700 employees.
Which technologies are used by Sarepta Therapeutics?
Sarepta Therapeutics utilizes technologies like PWA, Open Graph, Google Analytics.
Who is the Chief Executive Officer (CEO) of Sarepta Therapeutics?
The CEO of Sarepta Therapeutics is Douglas S. Ingram.
How can I get in touch with Sarepta Therapeutics?
To contact Sarepta Therapeutics, call 6172744000 or visit their website at www.sarepta.com
Is Sarepta Therapeutics a publicly traded company?
Yes, Sarepta Therapeutics is publicly listed and trades under the stock symbol SRPT.
How much total funding has Sarepta Therapeutics secured so far?
To date, Sarepta Therapeutics has raised $2.8B across 17 funding round(s).
Which industry is Sarepta Therapeutics part of?
Sarepta Therapeutics operates in the Pharmaceuticals, Healthcare industry.
Who are the main competitors of Sarepta Therapeutics?
Key competitors of Sarepta Therapeutics include Alnylam Pharmaceuticals, Ultragenyx, Ionis Pharmaceuticals, BioMarin
Which companies has Sarepta Therapeutics acquired?
Acquisitions by Sarepta Therapeutics include Ercole Biotech, Myonexus Therapeutics .
Who holds the CFO position at Sarepta Therapeutics?
Ian Estepan serves as the Chief Financial Officer (CFO) at Sarepta Therapeutics.
When did Sarepta Therapeutics complete its most recent funding round?
Sarepta Therapeutics latest funding round closed on Dec 13, 2019 with the amount of $250 Million
Who are the investors in Sarepta Therapeutics?
Sarepta Therapeutics is backed by 19 investors : CureDuchenne, Undisclosed, Undisclosed and Undisclosed.